{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:48:49Z","timestamp":1792003729358,"version":"4.4.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["FLF 106656"],"award-info":[{"award-number":["FLF 106656"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2029117"],"award-info":[{"award-number":["2029117"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["2016053"],"award-info":[{"award-number":["2016053"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00954-8","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:27:13Z","timestamp":1781504833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The asialoglycoprotein receptor 1 (ASGR1): emerging new roles in health and disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Demeke","family":"Geremew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne T. M.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Psaltis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Bursill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"954_CR1","doi-asserted-by":"publisher","first-page":"283974","DOI":"10.1155\/2012\/283974","volume":"2012","author":"RL Harris","year":"2012","unstructured":"Harris RL, van den Berg CW, Bowen DJ. ASGR1 and ASGR2, the Genes that Encode the Asialoglycoprotein Receptor (Ashwell Receptor), Are Expressed in Peripheral Blood Monocytes and Show Interindividual Differences in Transcript Profile. Mol Biol Int. 2012;2012:283974.","journal-title":"Mol Biol Int"},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.pmbts.2018.12.001","volume":"162","author":"M Wei","year":"2019","unstructured":"Wei M, Wang PG. Desialylation in physiological and pathological processes: New target for diagnostic and therapeutic development. Prog Mol Biol Transl Sci. 2019;162:25\u201357.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"954_CR3","doi-asserted-by":"crossref","unstructured":"Zhou X, Chi K, Zhang C, Liu Q, Yang G, Sialylation. A cloak for tumors to trick the immune system in the microenvironment. Biology (Basel). 2023;12(6).","DOI":"10.3390\/biology12060832"},{"issue":"24","key":"954_CR4","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.1016\/S0021-9258(18)60888-9","volume":"262","author":"J Bischoff","year":"1987","unstructured":"Bischoff J, Lodish HF. Two asialoglycoprotein receptor polypeptides in human hepatoma cells. J Biol Chem. 1987;262(24):11825\u201332.","journal-title":"J Biol Chem"},{"issue":"16","key":"954_CR5","doi-asserted-by":"publisher","first-page":"12624","DOI":"10.1074\/jbc.M011063200","volume":"276","author":"R Tozawa","year":"2001","unstructured":"Tozawa R, Ishibashi S, Osuga J, Yamamoto K, Yagyu H, Ohashi K, et al. Asialoglycoprotein receptor deficiency in mice lacking the major receptor subunit. Its obligate requirement for the stable expression of oligomeric receptor. J Biol Chem. 2001;276(16):12624\u20138.","journal-title":"J Biol Chem"},{"issue":"6400","key":"954_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/360127a0","volume":"360","author":"WI Weis","year":"1992","unstructured":"Weis WI, Drickamer K, Hendrickson WA. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature. 1992;360(6400):127\u201334.","journal-title":"Nature"},{"key":"954_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-immunol-031210-101352","volume":"30","author":"D Sancho","year":"2012","unstructured":"Sancho D, Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol. 2012;30:491\u2013529.","journal-title":"Annu Rev Immunol"},{"key":"954_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.sbi.2015.06.003","volume":"34","author":"K Drickamer","year":"2015","unstructured":"Drickamer K, Taylor ME. Recent insights into structures and functions of C-type lectins in the immune system. Curr Opin Struct Biol. 2015;34:26\u201334.","journal-title":"Curr Opin Struct Biol"},{"key":"954_CR9","doi-asserted-by":"publisher","first-page":"1653452","DOI":"10.3389\/fmed.2025.1653452","volume":"12","author":"X Xiao","year":"2025","unstructured":"Xiao X, Nie Y, Leng Y. Asialoglycoprotein receptor 1: a multifaceted receptor in the liver and cardiovascular system. Front Med (Lausanne). 2025;12:1653452.","journal-title":"Front Med (Lausanne)"},{"issue":"40","key":"954_CR10","doi-asserted-by":"publisher","first-page":"37798","DOI":"10.1074\/jbc.M204786200","volume":"277","author":"T Huang","year":"2002","unstructured":"Huang T, Deng H, Wolkoff AW, Stockert RJ. Phosphorylation-dependent interaction of the asialoglycoprotein receptor with molecular chaperones. J Biol Chem. 2002;277(40):37798\u2013803.","journal-title":"J Biol Chem"},{"key":"954_CR11","doi-asserted-by":"crossref","unstructured":"Hoober JK. ASGR1 and its enigmatic relative, CLEC10A. Int J Mol Sci. 2020;21(14).","DOI":"10.3390\/ijms21144818"},{"key":"954_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","volume":"57","author":"E Maverakis","year":"2015","unstructured":"Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, et al. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J Autoimmun. 2015;57:1\u201313.","journal-title":"J Autoimmun"},{"key":"954_CR13","doi-asserted-by":"publisher","first-page":"121339","DOI":"10.1016\/j.lfs.2022.121339","volume":"315","author":"R Shi","year":"2023","unstructured":"Shi R, Wang J, Zhang Z, Leng Y, Chen AF. ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-\u03baB\/ATF5 pathway. Life Sci. 2023;315:121339.","journal-title":"Life Sci"},{"issue":"43","key":"954_CR14","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.1021\/bi00495a001","volume":"29","author":"M Spiess","year":"1990","unstructured":"Spiess M. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry. 1990;29(43):10009\u201318.","journal-title":"Biochemistry"},{"issue":"3","key":"954_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1152\/physrev.1995.75.3.591","volume":"75","author":"RJ Stockert","year":"1995","unstructured":"Stockert RJ. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev. 1995;75(3):591\u2013609.","journal-title":"Physiol Rev"},{"issue":"7","key":"954_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.7150\/jca.11647","volume":"6","author":"Y Ma","year":"2015","unstructured":"Ma Y, Chen H, Su S, Wang T, Zhang C, Fida G, et al. Galactose as Broad Ligand for Multiple Tumor Imaging and Therapy. J Cancer. 2015;6(7):658\u201370.","journal-title":"J Cancer"},{"issue":"22","key":"954_CR17","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","volume":"374","author":"P Nioi","year":"2016","unstructured":"Nioi P, Sigurdsson A, Thorleifsson G, Helgason H, Agustsdottir AB, Norddahl GL, et al. Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. N Engl J Med. 2016;374(22):2131\u201341.","journal-title":"N Engl J Med"},{"issue":"12","key":"954_CR18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/CM9.0000000000000862","volume":"133","author":"X Zhao","year":"2020","unstructured":"Zhao X, Tang B, Shi ZH, Deng ZW, Deng Y, Tan LM, et al. Asialoglycoprotein receptor 1 gene expression in peripheral blood monocytes associates with serum total cholesterol and low-density lipoprotein cholesterol levels. Chin Med J (Engl). 2020;133(12):1505\u20136.","journal-title":"Chin Med J (Engl)"},{"issue":"7922","key":"954_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-022-05006-3","volume":"608","author":"JQ Wang","year":"2022","unstructured":"Wang JQ, Li LL, Hu A, Deng G, Wei J, Li YF, et al. Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion. Nature. 2022;608(7922):413\u201320.","journal-title":"Nature"},{"key":"954_CR20","doi-asserted-by":"publisher","first-page":"108614","DOI":"10.1016\/j.jmgm.2023.108614","volume":"125","author":"S Gao","year":"2023","unstructured":"Gao S, Wang L, Bai F, Xu S. In silico discovery of food-derived phytochemicals against asialoglycoprotein receptor 1 for treatment of hypercholesterolemia: Pharmacophore modeling, molecular docking and molecular dynamics simulation approach. J Mol Graph Model. 2023;125:108614.","journal-title":"J Mol Graph Model"},{"issue":"5","key":"954_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1172\/JCI0216001","volume":"110","author":"L Yu","year":"2002","unstructured":"Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest. 2002;110(5):671\u201380.","journal-title":"J Clin Invest"},{"issue":"11","key":"954_CR22","doi-asserted-by":"publisher","first-page":"e1009891","DOI":"10.1371\/journal.pgen.1009891","volume":"17","author":"B Xie","year":"2021","unstructured":"Xie B, Shi X, Li Y, Xia B, Zhou J, Du M, et al. Deficiency of ASGR1 in pigs recapitulates reduced risk factor for cardiovascular disease in humans. PLoS Genet. 2021;17(11):e1009891.","journal-title":"PLoS Genet"},{"issue":"1","key":"954_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41392-023-01319-5","volume":"8","author":"W Zhao","year":"2023","unstructured":"Zhao W, Xu S, Weng J. ASGR1: an emerging therapeutic target in hypercholesterolemia. Signal Transduct Target Ther. 2023;8(1):43.","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"954_CR24","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.molcel.2025.08.021","volume":"85","author":"S Shin","year":"2025","unstructured":"Shin S, Han M-J, Patel I, Welsh AM, Sverdlov M, Cho W, et al. mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport. Mol Cell. 2025;85(18):3486\u2013. \u2013\u2009504.e7.","journal-title":"Mol Cell"},{"key":"954_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ebiom.2018.05.009","volume":"31","author":"M Foretz","year":"2018","unstructured":"Foretz M, Viollet B. Activation of AMPK for a Break in Hepatic Lipid Accumulation and Circulating Cholesterol. EBioMedicine. 2018;31:15\u20136.","journal-title":"EBioMedicine"},{"issue":"12","key":"954_CR26","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1161\/ATVBAHA.124.321076","volume":"44","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Jiang X, Wang W, Lei L, Sheng R, Li S, et al. ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed ApoE(-\/-) Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux. Arterioscler Thromb Vasc Biol. 2024;44(12):2428\u201349.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"954_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/jci.insight.147038","volume":"6","author":"Y Xu","year":"2021","unstructured":"Xu Y, Tao J, Yu X, Wu Y, Chen Y, You K, et al. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression. JCI Insight. 2021;6:19.","journal-title":"JCI Insight"},{"issue":"4","key":"954_CR28","doi-asserted-by":"publisher","first-page":"101177","DOI":"10.1016\/j.jbc.2021.101177","volume":"297","author":"D Susan-Resiga","year":"2021","unstructured":"Susan-Resiga D, Girard E, Essalmani R, Roubtsova A, Marcinkiewicz J, Derbali RM, et al. Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin. J Biol Chem. 2021;297(4):101177.","journal-title":"J Biol Chem"},{"issue":"1","key":"954_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chembiol.2022.12.003","volume":"30","author":"JT Bagdanoff","year":"2023","unstructured":"Bagdanoff JT, Smith TM, Allan M, O\u2019Donnell P, Nguyen Z, Moore EA, et al. Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligands. Cell Chem Biol. 2023;30(1):97\u2013e1099.","journal-title":"Cell Chem Biol"},{"issue":"20","key":"954_CR30","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.1073\/pnas.162488899","volume":"99","author":"D Yabe","year":"2002","unstructured":"Yabe D, Brown MS, Goldstein JL. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci U S A. 2002;99(20):12753\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"954_CR31","doi-asserted-by":"publisher","first-page":"795370","DOI":"10.3389\/fcvm.2021.795370","volume":"8","author":"R Zhang","year":"2021","unstructured":"Zhang R. The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels. Front Cardiovasc Med. 2021;8:795370.","journal-title":"Front Cardiovasc Med"},{"issue":"26","key":"954_CR32","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1182\/blood.2023023559","volume":"143","author":"Y Sun","year":"2024","unstructured":"Sun Y, Tong H, Chu X, Li Y, Zhang J, Ding Y, et al. Notch1 regulates hepatic thrombopoietin production. Blood. 2024;143(26):2778\u201390.","journal-title":"Blood"},{"key":"954_CR33","doi-asserted-by":"publisher","first-page":"5638943","DOI":"10.1155\/2016\/5638943","volume":"2016","author":"W Cai","year":"2016","unstructured":"Cai W, Yang X, Han S, Guo H, Zheng Z, Wang H, et al. Notch1 Pathway Protects against Burn-Induced Myocardial Injury by Repressing Reactive Oxygen Species Production through JAK2\/STAT3 Signaling. Oxid Med Cell Longev. 2016;2016:5638943.","journal-title":"Oxid Med Cell Longev"},{"key":"954_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2016.01.007","volume":"72","author":"WD Qin","year":"2016","unstructured":"Qin WD, Zhang F, Qin XJ, Wang J, Meng X, Wang H, et al. Notch1 inhibition reduces low shear stress-induced plaque formation. Int J Biochem Cell Biol. 2016;72:63\u201372.","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"954_CR35","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/01.ATV.20.12.2630","volume":"20","author":"MC Bourdillon","year":"2000","unstructured":"Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, McGregor JL. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-\/-)\/ICAM-1(-\/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol. 2000;20(12):2630\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"954_CR36","doi-asserted-by":"publisher","first-page":"L200","DOI":"10.1152\/ajplung.00346.2005","volume":"291","author":"A Basit","year":"2006","unstructured":"Basit A, Reutershan J, Morris MA, Solga M, Rose CE Jr., Ley K. ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space. Am J Physiol Lung Cell Mol Physiol. 2006;291(2):L200\u20137.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"954_CR37","doi-asserted-by":"crossref","unstructured":"Vieceli Dalla Sega F, Fortini F, Aquila G, Campo G, Vaccarezza M, Rizzo P. Notch signaling regulates immune responses in atherosclerosis. Front Immunol. 2019;10.","DOI":"10.3389\/fimmu.2019.01130"},{"issue":"1","key":"954_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12933-023-02099-6","volume":"23","author":"M Svecla","year":"2024","unstructured":"Svecla M, Da Dalt L, Moregola A, Nour J, Baragetti A, Uboldi P, et al. ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity. Cardiovasc Diabetol. 2024;23(1):42.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"954_CR39","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1038\/s41598-019-40419-7","volume":"9","author":"T Nakajima","year":"2019","unstructured":"Nakajima T, Yokota T, Shingu Y, Yamada A, Iba Y, Ujihira K, et al. Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis. Sci Rep. 2019;9(1):3535.","journal-title":"Sci Rep"},{"issue":"10","key":"954_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11883-020-00870-8","volume":"22","author":"K Tian","year":"2020","unstructured":"Tian K, Xu Y, Sahebkar A, Xu S. CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications. Curr Atheroscler Rep. 2020;22(10):59.","journal-title":"Curr Atheroscler Rep"},{"key":"954_CR41","doi-asserted-by":"crossref","unstructured":"Bogan BJ, Williams HC, Holden CM, Patel V, Joseph G, Fierro C, et al. The role of fatty acid synthase in the vascular smooth muscle cell to foam cell transition. Cells. 2024;13(8).","DOI":"10.3390\/cells13080658"},{"issue":"47","key":"954_CR42","doi-asserted-by":"publisher","first-page":"eabq1984","DOI":"10.1126\/sciadv.abq1984","volume":"8","author":"S Yeudall","year":"2022","unstructured":"Yeudall S, Upchurch CM, Seegren PV, Pavelec CM, Greulich J, Lemke MC, et al. Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism. Sci Adv. 2022;8(47):eabq1984.","journal-title":"Sci Adv"},{"issue":"24","key":"954_CR43","doi-asserted-by":"publisher","first-page":"15196","DOI":"10.18632\/aging.205342","volume":"15","author":"M Zhang","year":"2023","unstructured":"Zhang M, Yue X, Zhao X, Lu Y, Liu H, Zhang Z, et al. Macrophage-specific deletion of Notch-1 induced M2 anti-inflammatory effect in atherosclerosis via activation of the PI3K-oxidative stress axis. Aging. 2023;15(24):15196\u2013212.","journal-title":"Aging"},{"issue":"1","key":"954_CR44","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-017-01741-8","volume":"8","author":"JJ Mack","year":"2017","unstructured":"Mack JJ, Mosqueiro TS, Archer BJ, Jones WM, Sunshine H, Faas GC, et al. NOTCH1 is a mechanosensor in adult arteries. Nat Commun. 2017;8(1):1620.","journal-title":"Nat Commun"},{"issue":"21","key":"954_CR45","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-21-4337","volume":"82","author":"X Zhu","year":"2022","unstructured":"Zhu X, Song G, Zhang S, Chen J, Hu X, Zhu H, et al. Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3. Cancer Res. 2022;82(21):3987\u20134000.","journal-title":"Cancer Res"},{"key":"954_CR46","doi-asserted-by":"publisher","first-page":"36790","DOI":"10.1038\/srep36790","volume":"6","author":"R Wang","year":"2016","unstructured":"Wang R, Zhang Y, Xu L, Lin Y, Yang X, Bai L, et al. Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice. Sci Rep. 2016;6:36790.","journal-title":"Sci Rep"},{"issue":"20","key":"954_CR47","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1158\/0008-5472.CAN-11-1773","volume":"71","author":"S Ueno","year":"2011","unstructured":"Ueno S, Mojic M, Ohashi Y, Higashi N, Hayakawa Y, Irimura T. Asialoglycoprotein receptor promotes cancer metastasis by activating the EGFR-ERK pathway. Cancer Res. 2011;71(20):6419\u201327.","journal-title":"Cancer Res"},{"key":"954_CR48","doi-asserted-by":"publisher","first-page":"3872367","DOI":"10.1155\/2020\/3872367","volume":"2020","author":"T Li","year":"2020","unstructured":"Li T, Li X, Feng Y, Dong G, Wang Y, Yang J. The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability. Mediators Inflamm. 2020;2020:3872367.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"954_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2004.04.012","volume":"176","author":"DJ Lamb","year":"2004","unstructured":"Lamb DJ, Modjtahedi H, Plant NJ, Ferns GA. EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis. 2004;176(1):21\u20136.","journal-title":"Atherosclerosis"},{"key":"954_CR50","doi-asserted-by":"publisher","first-page":"45917","DOI":"10.1038\/srep45917","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Huang Z, Huang W, Chen X, Shan P, Zhong P, et al. Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress. Sci Rep. 2017;8:45917.","journal-title":"Sci Rep"},{"issue":"19","key":"954_CR51","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/emboj.2009.239","volume":"28","author":"HJ Park","year":"2009","unstructured":"Park HJ, Carr JR, Wang Z, Nogueira V, Hay N, Tyner AL, et al. FoxM1, a critical regulator of oxidative stress during oncogenesis. Embo j. 2009;28(19):2908\u201318.","journal-title":"Embo j"},{"issue":"1","key":"954_CR52","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","volume":"237","author":"H Li","year":"2014","unstructured":"Li H, Horke S, F\u00f6rstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014;237(1):208\u201319.","journal-title":"Atherosclerosis"},{"key":"954_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.02.005","volume":"271","author":"A Eltoft","year":"2018","unstructured":"Eltoft A, Arntzen KA, Wilsgaard T, Mathiesen EB, Johnsen SH. Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Troms\u00f8 Study. Atherosclerosis. 2018;271:1\u20138.","journal-title":"Atherosclerosis"},{"issue":"20","key":"954_CR54","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/eurheartj\/ehx098","volume":"38","author":"M Nahrendorf","year":"2017","unstructured":"Nahrendorf M, Swirski FK, Cholesterol. CCR2, and monocyte phenotypes in atherosclerosis. Eur Heart J. 2017;38(20):1594\u20136.","journal-title":"Eur Heart J"},{"issue":"13\u201314","key":"954_CR55","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.cca.2011.03.036","volume":"412","author":"H Liu","year":"2011","unstructured":"Liu H, Jiang D. Fractalkine\/CX3CR1 and atherosclerosis. Clin Chim Acta. 2011;412(13\u201314):1180\u20136.","journal-title":"Clin Chim Acta"},{"key":"954_CR56","doi-asserted-by":"crossref","unstructured":"Jebari-Benslaiman S, Galicia-Garc\u00eda U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022;23(6).","DOI":"10.3390\/ijms23063346"},{"issue":"4","key":"954_CR57","doi-asserted-by":"publisher","first-page":"e018756","DOI":"10.1161\/JAHA.120.018756","volume":"10","author":"EP Demina","year":"2021","unstructured":"Demina EP, Smutova V, Pan X, Fougerat A, Guo T, Zou C, et al. Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages. J Am Heart Assoc. 2021;10(4):e018756.","journal-title":"J Am Heart Assoc"},{"key":"954_CR58","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/j.atherosclerosis.2020.10.349","volume":"315","author":"DA Kashirskikh","year":"2020","unstructured":"Kashirskikh DA, Markin AM, Sobenin IA, Orekhov AN. Study of the role of human endogenous neuraminidases in atherosclerotic lesions of the thoracic aorta. Atherosclerosis. 2020;315:e114\u20135.","journal-title":"Atherosclerosis"},{"issue":"7","key":"954_CR59","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S0022-2275(20)32017-4","volume":"41","author":"N Lindbohm","year":"2000","unstructured":"Lindbohm N, Gylling H, Miettinen TA. Sialic acid content of low density lipoprotein and its relation to lipid concentrations and metabolism of low density lipoprotein and cholesterol. J Lipid Res. 2000;41(7):1110\u20137.","journal-title":"J Lipid Res"},{"key":"954_CR60","doi-asserted-by":"crossref","unstructured":"Yu X, Tao J, Wu Y, Chen Y, Li P, Yang F, et al. Deficiency of ASGR1 alleviates diet-induced systemic insulin resistance via improved hepatic insulin sensitivity. Diabetes Metab J. 2024.","DOI":"10.4093\/dmj.2023.0124"},{"issue":"3","key":"954_CR61","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2337\/diacare.27.3.781","volume":"27","author":"M Rewers","year":"2004","unstructured":"Rewers M, Zaccaro D, D\u2019Agostino R, Haffner S, Saad MF, Selby JV, et al. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27(3):781\u20137.","journal-title":"Diabetes Care"},{"issue":"2","key":"954_CR62","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","volume":"7","author":"D Santoleri","year":"2019","unstructured":"Santoleri D, Titchenell PM. Resolving the Paradox of Hepatic Insulin Resistance. Cell Mol Gastroenterol Hepatol. 2019;7(2):447\u201356.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"954_CR63","first-page":"e201614","volume":"2016","author":"M Hassan","year":"2016","unstructured":"Hassan M, Wagdy K. ASGR1 - a new target for lowering non-HDL cholesterol. Glob Cardiol Sci Pract. 2016;2016(2):e201614.","journal-title":"Glob Cardiol Sci Pract"},{"issue":"8","key":"954_CR64","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jdiacomp.2019.05.008","volume":"33","author":"H Hamledari","year":"2019","unstructured":"Hamledari H, Sajjadi SF, Alikhah A, Boroumand MA, Behmanesh M. ASGR1 but not FOXM1 expression decreases in the peripheral blood mononuclear cells of diabetic atherosclerotic patients. J Diabetes Complications. 2019;33(8):539\u201346.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"954_CR65","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12944-023-01910-3","volume":"22","author":"Q Luo","year":"2023","unstructured":"Luo Q, Chen J, Su Y, Wu P, Wang J, Fang Z, et al. Correlation between serum soluble ASGR1 concentration and low-density lipoprotein cholesterol levels: a cross-sectional study. Lipids Health Dis. 2023;22(1):142.","journal-title":"Lipids Health Dis"},{"key":"954_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2020.07.001","volume":"306","author":"L Ali","year":"2020","unstructured":"Ali L, Cupido AJ, Rijkers M, Hovingh GK, Holleboom AG, Dallinga-Thie GM, et al. Common gene variants in ASGR1 gene locus associate with reduced cardiovascular risk in absence of pleiotropic effects. Atherosclerosis. 2020;306:15\u201321.","journal-title":"Atherosclerosis"},{"issue":"1","key":"954_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nm.3770","volume":"21","author":"R Grozovsky","year":"2015","unstructured":"Grozovsky R, Begonja AJ, Liu K, Visner G, Hartwig JH, Falet H, et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med. 2015;21(1):47\u201354.","journal-title":"Nat Med"},{"issue":"12","key":"954_CR68","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1194\/jlr.M027300","volume":"53","author":"A Yang","year":"2012","unstructured":"Yang A, Gyulay G, Mitchell M, White E, Trigatti BL, Igdoura SA. Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice. J Lipid Res. 2012;53(12):2573\u201385.","journal-title":"J Lipid Res"},{"issue":"6","key":"954_CR69","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1182\/blood-2006-06-032706","volume":"109","author":"CJ van Schooten","year":"2007","unstructured":"van Schooten CJ, Denis CV, Lisman T, Eikenboom JC, Leebeek FW, Goudemand J, et al. Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels. Blood. 2007;109(6):2430\u20137.","journal-title":"Blood"},{"issue":"6","key":"954_CR70","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nm1760","volume":"14","author":"PK Grewal","year":"2008","unstructured":"Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med. 2008;14(6):648\u201355.","journal-title":"Nat Med"},{"issue":"8","key":"954_CR71","first-page":"911","volume":"131","author":"SE Ward","year":"2018","unstructured":"Ward SE, O\u2019Sullivan JM, Drakeford C, Aguila S, Jondle CN, Sharma J, et al. A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance. Blood J Am Soc Hematol. 2018;131(8):911\u20136.","journal-title":"Blood J Am Soc Hematol"},{"issue":"36","key":"954_CR72","doi-asserted-by":"publisher","first-page":"18700","DOI":"10.1074\/jbc.M116.738948","volume":"291","author":"Y Mi","year":"2016","unstructured":"Mi Y, Coonce M, Fiete D, Steirer L, Dveksler G, Townsend RR, et al. Functional Consequences of Mannose and Asialoglycoprotein Receptor Ablation. J Biol Chem. 2016;291(36):18700\u201317.","journal-title":"J Biol Chem"},{"issue":"11","key":"954_CR73","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/glycob\/cwad083","volume":"33","author":"B Tumoglu","year":"2023","unstructured":"Tumoglu B, Keelaghan A, Avci FY. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease. Glycobiology. 2023;33(11):879\u201387.","journal-title":"Glycobiology"},{"key":"954_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.030","volume":"143","author":"R Zhao","year":"2017","unstructured":"Zhao R, Li T, Zheng G, Jiang K, Fan L, Shao J. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex. Biomaterials. 2017;143:1\u201316.","journal-title":"Biomaterials"},{"key":"954_CR75","unstructured":"Cortes GA, Moore MJ, El-Nakeep S. Physiology, Von Willebrand Factor. StatPearls. Treasure Island (FL). StatPearls Publishing LLC.; 2024. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/32644488\/. Accessed19 May 2024."},{"key":"954_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.scr.2017.05.006","volume":"22","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wu Y, Guo D, Gao G, Lai K, Yang F, et al. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR\/Cas9. Stem Cell Res. 2017;22:29\u201332.","journal-title":"Stem Cell Res"},{"issue":"7","key":"954_CR77","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.bcp.2008.12.023","volume":"77","author":"SR Dalton","year":"2009","unstructured":"Dalton SR, Lee SM, King RN, Nanji AA, Kharbanda KK, Casey CA, et al. Carbon tetrachloride-induced liver damage in asialoglycoprotein receptor-deficient mice. Biochem Pharmacol. 2009;77(7):1283\u201390.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"954_CR78","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41467-024-46135-9","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Leng XK, Zhai YY, Zhang X, Sun ZW, Xiao JY, et al. Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress. Nat Commun. 2024;15(1):1908.","journal-title":"Nat Commun"},{"key":"954_CR79","doi-asserted-by":"crossref","unstructured":"Rasineni K, Lee SML, McVicker BL, Osna NA, Casey CA, Kharbanda KK. Susceptibility of asialoglycoprotein receptor-deficient mice to Lps\/galactosamine liver injury and protection by betaine administration. Biology (Basel). 2020;10(1).","DOI":"10.3390\/biology10010019"},{"issue":"5","key":"954_CR80","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/labinvest.2015.34","volume":"95","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhu L, Liang S, Yao S, Li R, Liu S, et al. Galactose protects hepatocytes against TNF-\u03b1-induced apoptosis by promoting activation of the NF-\u03baB signaling pathway in acute liver failure. Lab Invest. 2015;95(5):504\u201314.","journal-title":"Lab Invest"},{"key":"954_CR81","doi-asserted-by":"crossref","unstructured":"Lebeau PF, Wassef H, Byun JH, Platko K, Ason B, Jackson S, et al. The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury. J Clin Invest. 2021;131(2).","DOI":"10.1172\/JCI128650"},{"issue":"8","key":"954_CR82","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1136\/gutjnl-2014-308506","volume":"65","author":"CY Han","year":"2016","unstructured":"Han CY, Lim SW, Koo JH, Kim W, Kim SG. PHLDA3 overexpression in hepatocytes by endoplasmic reticulum stress via IRE1-Xbp1s pathway expedites liver injury. Gut. 2016;65(8):1377\u201388.","journal-title":"Gut"},{"issue":"9","key":"954_CR83","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/hep4.1404","volume":"3","author":"J Li","year":"2019","unstructured":"Li J, Liu H, Mauer AS, Lucien F, Raiter A, Bandla H, et al. Characterization of Cellular Sources and Circulating Levels of Extracellular Vesicles in a Dietary Murine Model of Nonalcoholic Steatohepatitis. Hepatol Commun. 2019;3(9):1235\u201349.","journal-title":"Hepatol Commun"},{"issue":"20","key":"954_CR84","doi-asserted-by":"publisher","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","volume":"271","author":"SS Lee","year":"1996","unstructured":"Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem. 1996;271(20):12063\u20137.","journal-title":"J Biol Chem"},{"issue":"7","key":"954_CR85","doi-asserted-by":"publisher","first-page":"110288","DOI":"10.1016\/j.isci.2024.110288","volume":"27","author":"Y Yin","year":"2024","unstructured":"Yin Y, Liu J, Yu J, Dong D, Gao F, Yu L, et al. ASGR1 is a promising target for lipid reduction in pigs with PON2 as its inhibitor. iScience. 2024;27(7):110288.","journal-title":"iScience"},{"issue":"1","key":"954_CR86","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12933-024-02507-5","volume":"23","author":"M Svecla","year":"2024","unstructured":"Svecla M, Moregola A, Dalt LD, Nour J, Baragetti A, Uboldi P, et al. ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE(-\/-) mice. Cardiovasc Diabetol. 2024;23(1):428.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"954_CR87","doi-asserted-by":"publisher","first-page":"100615","DOI":"10.1016\/j.mcpro.2023.100615","volume":"22","author":"M Svecla","year":"2023","unstructured":"Svecla M, Nour J, Bladergroen MR, Nicolardi S, Zhang T, Beretta G, et al. Impact of Asialoglycoprotein Receptor and Mannose Receptor Deficiency on Murine Plasma N-glycome Profiles. Mol Cell Proteom. 2023;22(9):100615.","journal-title":"Mol Cell Proteom"},{"issue":"11","key":"954_CR88","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.970","volume":"43","author":"JC Chambers","year":"2011","unstructured":"Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet. 2011;43(11):1131\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"954_CR89","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nri2417","volume":"8","author":"JD Marth","year":"2008","unstructured":"Marth JD, Grewal PK. Mammalian glycosylation in immunity. Nat Rev Immunol. 2008;8(11):874\u201387.","journal-title":"Nat Rev Immunol"},{"issue":"5512","key":"954_CR90","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1126\/science.291.5512.2370","volume":"291","author":"PM Rudd","year":"2001","unstructured":"Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science. 2001;291(5512):2370\u20136.","journal-title":"Science"},{"issue":"1","key":"954_CR91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1084\/jem.20110399","volume":"209","author":"D Li","year":"2012","unstructured":"Li D, Romain G, Flamar AL, Duluc D, Dullaers M, Li XH, et al. Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4\u2009+\u2009T cells. J Exp Med. 2012;209(1):109\u201321.","journal-title":"J Exp Med"},{"issue":"3","key":"954_CR92","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/hep.24477","volume":"54","author":"CS Guy","year":"2011","unstructured":"Guy CS, Rankin SL, Michalak TI. Hepatocyte cytotoxicity is facilitated by asialoglycoprotein receptor. Hepatology. 2011;54(3):1043\u201350.","journal-title":"Hepatology"},{"issue":"1","key":"954_CR93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/jimmunol.1501668","volume":"196","author":"IN Crispe","year":"2016","unstructured":"Crispe IN. Hepatocytes as Immunological Agents. J Immunol. 2016;196(1):17\u201321.","journal-title":"J Immunol"},{"issue":"9","key":"954_CR94","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2174\/1566524015666151026102143","volume":"15","author":"F Sierro","year":"2015","unstructured":"Sierro F, Tay SS, Warren A, Le Couteur DG, McCaughan GW, Bowen DG, et al. Suicidal emperipolesis: a process leading to cell-in-cell structures, T cell clearance and immune homeostasis. Curr Mol Med. 2015;15(9):819\u201327.","journal-title":"Curr Mol Med"},{"key":"954_CR95","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-cellbio-120420-114855","volume":"38","author":"LE O\u2019Brien","year":"2022","unstructured":"O\u2019Brien LE. Tissue Homeostasis and Non-Homeostasis: From Cell Life Cycles to Organ States. Annu Rev Cell Dev Biol. 2022;38:395\u2013418.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"25","key":"954_CR96","doi-asserted-by":"publisher","first-page":"e2201129119","DOI":"10.1073\/pnas.2201129119","volume":"119","author":"AT Linder","year":"2022","unstructured":"Linder AT, Schmidt M, Hitschfel J, Abeln M, Schneider P, Gerardy-Schahn R, et al. Sialic acids on B cells are crucial for their survival and provide protection against apoptosis. Proc Natl Acad Sci U S A. 2022;119(25):e2201129119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"954_CR97","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.bbagen.2009.07.027","volume":"1790","author":"S Bi","year":"2009","unstructured":"Bi S, Baum LG. Sialic acids in T cell development and function. Biochim Biophys Acta. 2009;1790(12):1599\u2013610.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"954_CR98","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S1074-7613(94)80016-2","volume":"1","author":"L Huang","year":"1994","unstructured":"Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity. 1994;1(9):741\u20139.","journal-title":"Immunity"},{"key":"954_CR99","doi-asserted-by":"crossref","unstructured":"Schmidt M, Linder AT, Korn M, Schellenberg N, Meyer SJ, Nimmerjahn F, et al. Sialic acids on T cells are crucial for their maintenance and survival. Front Immunol. 2024;15.","DOI":"10.3389\/fimmu.2024.1359494"},{"issue":"2","key":"954_CR100","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.autrev.2012.04.005","volume":"12","author":"EI Rigopoulou","year":"2012","unstructured":"Rigopoulou EI, Roggenbuck D, Smyk DS, Liaskos C, Mytilinaiou MG, Feist E, et al. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev. 2012;12(2):260\u20139.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"954_CR101","first-page":"347","volume":"55","author":"IG McFarlane","year":"1984","unstructured":"McFarlane IG, McFarlane BM, Major GN, Tolley P, Williams R. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol. 1984;55(2):347\u201354.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"954_CR102","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/hep.1840120611","volume":"12","author":"H L\u00f6hr","year":"1990","unstructured":"L\u00f6hr H, Treichel U, Poralla T, Manns M, Meyer zum B\u00fcschenfelde KH, Fleischer B. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology. 1990;12(6):1314\u201320.","journal-title":"Hepatology"},{"issue":"6","key":"954_CR103","first-page":"G1189","volume":"277","author":"RF Rotundo","year":"1999","unstructured":"Rotundo RF, Vincent PA, McKeown-Longo PJ, Blumenstock FA, Saba TM. Hepatic fibronectin matrix turnover in rats: involvement of the asialoglycoprotein receptor. Am J Physiol. 1999;277(6):G1189\u201399.","journal-title":"Am J Physiol"},{"issue":"20","key":"954_CR104","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1073\/pnas.79.20.6229","volume":"79","author":"RJ Stockert","year":"1982","unstructured":"Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG. IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci U S A. 1982;79(20):6229\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"954_CR105","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.191.12.2171","volume":"191","author":"A Rifai","year":"2000","unstructured":"Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med. 2000;191(12):2171\u201382.","journal-title":"J Exp Med"},{"issue":"5","key":"954_CR106","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cell.2020.02.019","volume":"180","author":"HY Chew","year":"2020","unstructured":"Chew HY, De Lima PO, Gonzalez Cruz JL, Banushi B, Echejoh G, Hu L, et al. Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies. Cell. 2020;180(5):895\u2013e91427.","journal-title":"Cell"},{"key":"954_CR107","doi-asserted-by":"publisher","first-page":"681372","DOI":"10.3389\/fcell.2021.681372","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wei H, Fan L, Fang M, He X, Lu B, et al. CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment. Front Cell Dev Biol. 2021;9:681372.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"954_CR108","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/xen.12164","volume":"22","author":"LL Paris","year":"2015","unstructured":"Paris LL, Estrada JL, Li P, Blankenship RL, Sidner RA, Reyes LM, et al. Reduced human platelet uptake by pig livers deficient in the asialoglycoprotein receptor 1 protein. Xenotransplantation. 2015;22(3):203\u201310.","journal-title":"Xenotransplantation"},{"issue":"3","key":"954_CR109","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1399-3089.2011.00642.x","volume":"18","author":"B Ekser","year":"2011","unstructured":"Ekser B, Gridelli B, Veroux M, Cooper DK. Clinical pig liver xenotransplantation: how far do we have to go? Xenotransplantation. 2011;18(3):158\u201367.","journal-title":"Xenotransplantation"},{"key":"954_CR110","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2023.01.007","volume":"644","author":"B Hou","year":"2023","unstructured":"Hou B, Qin L, Huang L. Liver cancer cells as the model for developing liver-targeted RNAi therapeutics. Biochem Biophys Res Commun. 2023;644:85\u201394.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"954_CR111","first-page":"8862","volume":"14","author":"T Huang","year":"2022","unstructured":"Huang T. SARS-CoV-2-correlated ASGR1 is a novel potential marker for the treatment and identification of multiple human cancers. Am J Transl Res. 2022;14(12):8862\u201378.","journal-title":"Am J Transl Res"},{"issue":"2","key":"954_CR112","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jhep.2017.02.024","volume":"67","author":"H Julich-Haertel","year":"2017","unstructured":"Julich-Haertel H, Urban SK, Krawczyk M, Willms A, Jankowski K, Patkowski W, et al. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma. J Hepatol. 2017;67(2):282\u201392.","journal-title":"J Hepatol"},{"issue":"10","key":"954_CR113","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3727\/096504009789735440","volume":"17","author":"J Fang","year":"2009","unstructured":"Fang J, Izawa R, Gomez-Santos L, Ueno S, Sawaguchi T, Usami K, et al. Potentiation of proliferation of some but not all human colon carcinoma cell lines by immobilized hepatic asialoglycoprotein receptor 1. Oncol Res. 2009;17(10):437\u201345.","journal-title":"Oncol Res"},{"issue":"9","key":"954_CR114","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00432-018-2685-6","volume":"144","author":"SR Lee","year":"2018","unstructured":"Lee SR, Choi YD, Cho NH. Association between pathologic factors and ERG expression in prostate cancer: finding pivotal networking. J Cancer Res Clin Oncol. 2018;144(9):1665\u201383.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"954_CR115","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1097\/MPA.0000000000002229","volume":"52","author":"T Liu","year":"2023","unstructured":"Liu T, Chen J, Liu AA, Chen L, Liang X, Peng JF, et al. Identifying Liver Metastasis-Related Genes Through a Coexpression Network to Construct a 5-Gene Model for Predicting Pancreatic Ductal Adenocarcinoma Patient Prognosis. Pancreas. 2023;52(2):e151\u201362.","journal-title":"Pancreas"},{"issue":"7","key":"954_CR116","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/hepr.12599","volume":"46","author":"D Witzigmann","year":"2016","unstructured":"Witzigmann D, Quagliata L, Schenk SH, Quintavalle C, Terracciano LM, Huwyler J. Variable asialoglycoprotein receptor 1 expression in liver disease: Implications for therapeutic intervention. Hepatol Res. 2016;46(7):686\u201396.","journal-title":"Hepatol Res"},{"issue":"1","key":"954_CR117","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2016.05.030","volume":"379","author":"D Gu","year":"2016","unstructured":"Gu D, Jin H, Jin G, Wang C, Wang N, Hu F, et al. The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity. Cancer Lett. 2016;379(1):107\u201316.","journal-title":"Cancer Lett"},{"key":"954_CR118","doi-asserted-by":"publisher","first-page":"1074277","DOI":"10.3389\/fmolb.2022.1074277","volume":"9","author":"A Roa-Colomo","year":"2022","unstructured":"Roa-Colomo A, L\u00f3pez Garrido M, Molina-Vallejo P, Rojas A, Sanchez MG, Aranda-Garc\u00eda V, et al. Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception. Front Mol Biosci. 2022;9:1074277.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"954_CR119","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.28079","volume":"133","author":"A Hendrix","year":"2013","unstructured":"Hendrix A, Sormunen R, Westbroek W, Lambein K, Denys H, Sys G, et al. Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. Int J Cancer. 2013;133(4):843\u201354.","journal-title":"Int J Cancer"},{"issue":"2","key":"954_CR120","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3892\/or.2013.2908","volume":"31","author":"L Chen","year":"2014","unstructured":"Chen L, Lu X, Zeng T, Chen Y, Chen Q, Wu W, et al. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-\u03b21-Smad4-PAI-1 axis. Oncol Rep. 2014;31(2):885\u201393.","journal-title":"Oncol Rep"},{"issue":"8\u20139","key":"954_CR121","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10719-012-9394-1","volume":"29","author":"T Miyagi","year":"2012","unstructured":"Miyagi T, Takahashi K, Hata K, Shiozaki K, Yamaguchi K. Sialidase significance for cancer progression. Glycoconj J. 2012;29(8\u20139):567\u201377.","journal-title":"Glycoconj J"},{"key":"954_CR122","doi-asserted-by":"crossref","unstructured":"Pietrobono S, Stecca B. Aberrant sialylation in cancer: biomarker and potential target for therapeutic intervention? Cancers (Basel). 2021;13(9).","DOI":"10.3390\/cancers13092014"},{"key":"954_CR123","doi-asserted-by":"publisher","first-page":"e12972","DOI":"10.1590\/1414-431x2023e12972","volume":"56","author":"AV Poznyak","year":"2023","unstructured":"Poznyak AV, Kashirskikh DA, Postnov AY, Popov MA, Sukhorukov VN, Orekhov AN. Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis. Braz J Med Biol Res. 2023;56:e12972.","journal-title":"Braz J Med Biol Res"},{"issue":"10","key":"954_CR124","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.celrep.2016.02.027","volume":"14","author":"S Gruber","year":"2016","unstructured":"Gruber S, Hendrikx T, Tsiantoulas D, Ozsvar-Kozma M, G\u00f6derle L, Mallat Z, et al. Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells. Cell Rep. 2016;14(10):2348\u201361.","journal-title":"Cell Rep"},{"key":"954_CR125","volume-title":"Liver Cancer - Genesis, Progression and Metastasis","author":"C Jin","year":"2022","unstructured":"Jin C, Wang B-S, Liu Y-Y. Mechanisms of Hepatocarcinogenesis Development in an Acidic Microenvironment. In: Feitelson MA, Arzumanyan A, editors. Liver Cancer - Genesis, Progression and Metastasis. London: IntechOpen; 2022."},{"issue":"8","key":"954_CR126","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1172\/JCI27920","volume":"116","author":"G Soong","year":"2006","unstructured":"Soong G, Muir A, Gomez MI, Waks J, Reddy B, Planet P, et al. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest. 2006;116(8):2297\u2013305.","journal-title":"J Clin Invest"},{"issue":"3","key":"954_CR127","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1248\/bpb.28.399","volume":"28","author":"Y Suzuki","year":"2005","unstructured":"Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull. 2005;28(3):399\u2013408.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"954_CR128","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1038\/s41467-024-47279-4","volume":"15","author":"LB Giron","year":"2024","unstructured":"Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, et al. Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection. Nat Commun. 2024;15(1):3035.","journal-title":"Nat Commun"},{"issue":"2","key":"954_CR129","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/viro.1996.8373","volume":"228","author":"NM Stamatos","year":"1997","unstructured":"Stamatos NM, Gomatos PJ, Cox J, Fowler A, Dow N, Wohlhieter JA, et al. Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1. Virology. 1997;228(2):123\u201331.","journal-title":"Virology"},{"issue":"3","key":"954_CR130","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3947\/ic.2021.0031","volume":"53","author":"D Lee","year":"2021","unstructured":"Lee D, Yoon CH, Choi SY, Kim JE, Cho YK, Choi BS, et al. Transcriptome Analysis Identifies Altered Biological Processes and Novel Markers in Human Immunodeficiency Virus-1 Long-Term Non-Progressors. Infect Chemother. 2021;53(3):489\u2013502.","journal-title":"Infect Chemother"},{"key":"954_CR131","doi-asserted-by":"publisher","first-page":"106050","DOI":"10.1016\/j.compbiomed.2022.106050","volume":"151","author":"A Achom","year":"2022","unstructured":"Achom A, Das R, Pakray P. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. Comput Biol Med. 2022;151:106050. Pt A).","journal-title":"Comput Biol Med"},{"issue":"1","key":"954_CR132","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41392-024-01754-y","volume":"9","author":"X Yang","year":"2024","unstructured":"Yang X, Zheng X, Zhu Y, Zhao X, Liu J, Xun J, et al. Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytes. Signal Transduct Target Ther. 2024;9(1):42.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"954_CR133","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/JVI.77.1.546-559.2003","volume":"77","author":"B Saunier","year":"2003","unstructured":"Saunier B, Triyatni M, Ulianich L, Maruvada P, Yen P, Kohn LD. Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol. 2003;77(1):546\u201359.","journal-title":"J Virol"},{"issue":"4","key":"954_CR134","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00705-010-0903-x","volume":"156","author":"X Zhang","year":"2011","unstructured":"Zhang X, Lin SM, Chen TY, Liu M, Ye F, Chen YR, et al. Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro. Arch Virol. 2011;156(4):637\u201345.","journal-title":"Arch Virol"},{"issue":"12","key":"954_CR135","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/jmv.24570","volume":"88","author":"L Zhang","year":"2016","unstructured":"Zhang L, Tian Y, Wen Z, Zhang F, Qi Y, Huang W, et al. Asialoglycoprotein receptor facilitates infection of PLC\/PRF\/5 cells by HEV through interaction with ORF2. J Med Virol. 2016;88(12):2186\u201395.","journal-title":"J Med Virol"},{"issue":"3","key":"954_CR136","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s007050050095","volume":"142","author":"U Treichel","year":"1997","unstructured":"Treichel U, Meyer zum B\u00fcschenfelde KH, Dienes HP, Gerken G. Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol. 1997;142(3):493\u20138.","journal-title":"Arch Virol"},{"issue":"1","key":"954_CR137","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2893.2005.00648.x","volume":"13","author":"T Owada","year":"2006","unstructured":"Owada T, Matsubayashi K, Sakata H, Ihara H, Sato S, Ikebuchi K, et al. Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry. J Viral Hepat. 2006;13(1):11\u20138.","journal-title":"J Viral Hepat"},{"issue":"3","key":"954_CR138","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","volume":"79","author":"P Gripon","year":"2005","unstructured":"Gripon P, Cannie I, Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol. 2005;79(3):1613\u201322.","journal-title":"J Virol"},{"issue":"1","key":"954_CR139","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","volume":"129","author":"D Glebe","year":"2005","unstructured":"Glebe D, Urban S, Knoop EV, Cag N, Krass P, Gr\u00fcn S, et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology. 2005;129(1):234\u201345.","journal-title":"Gastroenterology"},{"issue":"4","key":"954_CR140","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.patbio.2010.04.001","volume":"58","author":"Y Xie","year":"2010","unstructured":"Xie Y, Zhai J, Deng Q, Tiollais P, Wang Y, Zhao M. Entry of hepatitis B virus: mechanism and new therapeutic target. Pathol Biol (Paris). 2010;58(4):301\u20137.","journal-title":"Pathol Biol (Paris)"},{"issue":"7","key":"954_CR141","doi-asserted-by":"publisher","first-page":"102097","DOI":"10.1016\/j.jbc.2022.102097","volume":"298","author":"M Ide","year":"2022","unstructured":"Ide M, Tabata N, Yonemura Y, Shirasaki T, Murai K, Wang Y, et al. Guanine nucleotide exchange factor DOCK11-binding peptide fused with a single chain antibody inhibits hepatitis B virus infection and replication. J Biol Chem. 2022;298(7):102097.","journal-title":"J Biol Chem"},{"issue":"3","key":"954_CR142","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00441-013-1616-8","volume":"352","author":"P Sun","year":"2013","unstructured":"Sun P, Zheng J, She G, Wei X, Zhang X, Shi H, et al. Expression pattern of asialoglycoprotein receptor in human testis. Cell Tissue Res. 2013;352(3):761\u20138.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"954_CR143","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41422-021-00595-6","volume":"32","author":"Y Gu","year":"2022","unstructured":"Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, et al. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res. 2022;32(1):24\u201337.","journal-title":"Cell Res"},{"issue":"6","key":"954_CR144","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/his.14871","volume":"82","author":"K Br\u00e4utigam","year":"2023","unstructured":"Br\u00e4utigam K, Reinhard S, Wartenberg M, Forster S, Greif K, Granai M, et al. Comprehensive analysis of SARS-CoV-2 receptor proteins in human respiratory tissues identifies alveolar macrophages as potential virus entry site. Histopathology. 2023;82(6):846\u201359.","journal-title":"Histopathology"},{"issue":"4","key":"954_CR145","doi-asserted-by":"publisher","first-page":"e29579","DOI":"10.1002\/jmv.29579","volume":"96","author":"C Gandikota","year":"2024","unstructured":"Gandikota C, Vaddadi K, Sivasami P, Huang C, Liang Y, Pushparaj S, et al. The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses. J Med Virol. 2024;96(4):e29579.","journal-title":"J Med Virol"},{"issue":"7","key":"954_CR146","doi-asserted-by":"publisher","first-page":"e28280","DOI":"10.1016\/j.heliyon.2024.e28280","volume":"10","author":"F Gao","year":"2024","unstructured":"Gao F, Lin W, Wang X, Liao M, Zhang M, Qin N, et al. Identification of receptors and factors associated with human coronaviruses in the oral cavity using single-cell RNA sequencing. Heliyon. 2024;10(7):e28280.","journal-title":"Heliyon"},{"issue":"17","key":"954_CR147","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.1811064116","volume":"116","author":"M Iwamoto","year":"2019","unstructured":"Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, et al. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization. Proc Natl Acad Sci U S A. 2019;116(17):8487\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"954_CR148","first-page":"e78673","volume":"17","author":"N Ezzariga","year":"2025","unstructured":"Ezzariga N, Zouhari O, Rhars A, Lemkhente Z, Aghrouch M. Biofilm and Antibiotic Resistance Study of Bacteria Involved in Nosocomial Infections. Cureus. 2025;17(2):e78673.","journal-title":"Cureus"},{"key":"954_CR149","doi-asserted-by":"crossref","unstructured":"Cheng B, Xu P. Redox-sensitive nanocomplex for targeted delivery of melittin. Toxins (Basel). 2020;12(9).","DOI":"10.3390\/toxins12090582"},{"key":"954_CR150","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.actbio.2018.01.028","volume":"70","author":"R Zhao","year":"2018","unstructured":"Zhao R, Zheng G, Fan L, Shen Z, Jiang K, Guo Y, et al. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy. Acta Biomater. 2018;70:197\u2013210.","journal-title":"Acta Biomater"},{"key":"954_CR151","doi-asserted-by":"publisher","first-page":"109831","DOI":"10.1016\/j.msec.2019.109831","volume":"103","author":"Y Wu","year":"2019","unstructured":"Wu Y, Xu Z, Sun W, Yang Y, Jin H, Qiu L, et al. Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment. Mater Sci Eng C Mater Biol Appl. 2019;103:109831.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"954_CR152","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/10717544.2014.907373","volume":"23","author":"D Bansal","year":"2016","unstructured":"Bansal D, Yadav K, Pandey V, Ganeshpurkar A, Agnihotri A, Dubey N. Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma. Drug Deliv. 2016;23(1):140\u20136.","journal-title":"Drug Deliv"},{"issue":"9","key":"954_CR153","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ymthe.2019.06.009","volume":"27","author":"Y Kim","year":"2019","unstructured":"Kim Y, Jo M, Schmidt J, Luo X, Prakash TP, Zhou T, et al. Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models. Mol Ther. 2019;27(9):1547\u201357.","journal-title":"Mol Ther"},{"issue":"8","key":"954_CR154","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","volume":"28","author":"AJ Debacker","year":"2020","unstructured":"Debacker AJ, Voutila J, Catley M, Blakey D, Habib N. Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug. Mol Ther. 2020;28(8):1759\u201371.","journal-title":"Mol Ther"},{"key":"954_CR155","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ahj.2022.05.004","volume":"251","author":"ML O\u2019Donoghue","year":"2022","unstructured":"O\u2019Donoghue ML, JA GL, Knusel B, Gencer B, Wang H, Wu Y, et al. Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE). Am Heart J. 2022;251:61\u20139.","journal-title":"Am Heart J"},{"issue":"4","key":"954_CR156","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40268-021-00369-w","volume":"21","author":"SV Gupta","year":"2021","unstructured":"Gupta SV, Fanget MC, MacLauchlin C, Clausen VA, Li J, Cloutier D, et al. Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection. Drugs R D. 2021;21(4):455\u201365.","journal-title":"Drugs R D"},{"key":"954_CR157","doi-asserted-by":"publisher","first-page":"1090237","DOI":"10.3389\/fphar.2022.1090237","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liang Y, Liang G, Tian Z, Zhang Y, Liu Z, et al. The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates. Front Pharmacol. 2022;13:1090237.","journal-title":"Front Pharmacol"},{"issue":"21","key":"954_CR158","doi-asserted-by":"publisher","first-page":"12388","DOI":"10.1093\/nar\/gkx960","volume":"45","author":"M Tanowitz","year":"2017","unstructured":"Tanowitz M, Hettrick L, Revenko A, Kinberger GA, Prakash TP, Seth PP. Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes. Nucleic Acids Res. 2017;45(21):12388\u2013400.","journal-title":"Nucleic Acids Res"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00954-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:04:44Z","timestamp":1787792684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00954-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":158,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00954-8","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"98"}}